Specifically, the effects of APOE+ macrophages on ccRCC tumor progression, their contribution to reshaping the immune microenvironment, and their impact on immunotherapy and underlying mechanisms are not yet fully elucidated. The gene discussed is APOE; the disease is nonpapillary renal cell carcinoma.